Risk Indicators of Sarcoidosis Evolution-Unified Protocol

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
University of California, San Francisco
Study ID
NCT05567133
Status
Recruiting
Apply to this trial

Conditions

  • Sarcoidosis, Pulmonary

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.

Key Dates

Start date
Jan 10, 2023
Status verified
Jan 2026
Primary completion
Mar 30, 2030
Completion
Mar 30, 2030

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Mean Change in Forced Vital Capacity in Liters [ Time Frame: Baseline and 24 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of MarylandBaltimoreMaryland21201
Wonder P Drake, MD
[email protected]
UT SouthwesternDallasTexas75390
Fabiola Gianella
[email protected]
214-648-7875

Find similar trials in Baltimore, MD

By research site
University of Maryland· Baltimore, MDUT Southwestern· Dallas, TX

Related Studies